Aesthetic Medical International Holdings Group Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	no data
Board average tenure	1.3yrs

Recent management updates

Recent updates

CEO

Aesthetic Medical International Holdings Group has no CEO, or we have no data on them.

Board Members

Name	Position	Tenure	Compensation	Ownership
Pengwu Zhou	Co-Founder & Non-Executive Co-Chairman of the Board	1.3yrs	no data	0.79% € 89.8k
Chen Zhang	Executive co-chairman of the Board	1.3yrs	no data	no data
Bo Liu	Director	1.3yrs	no data	no data
Binqi Wu	Director	1.3yrs	no data	no data
Laurena Wu	Director	1.3yrs	no data	14.87% € 1.7m
Binhua Wu	Director	1.3yrs	no data	no data
Changsuo Zhang	Director	1.3yrs	no data	no data
Xichun Zhou	Director	1.3yrs	no data	0% € 0
Yingzhou Lin	Independent Director	1.3yrs	no data	no data
Yanyun Li	Independent Director	1.3yrs	no data	no data
Feng Chen	Independent Director	less than a year	no data	no data

1.3yrs

Average Tenure

42yo

Average Age

Experienced Board: 3FMA's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.

Aesthetic Medical International Holdings Group Management

Management criteria checks 0/4

Key information

Recent management updates

Aesthetic Medical International Holdings Group Limited Announces Change of Director

Aesthetic Medical International Holdings Group Limited Announces Board and Committee Changes

Less than half of directors are independent

Aesthetic Medical International Holdings Group Limited, Annual General Meeting, Sep 08, 2022

Less than half of directors are independent

Less than half of directors are independent

Recent updates

First half 2024 earnings released: CN¥0.45 loss per share (vs CN¥0.24 loss in 1H 2023)

New major risk - Market cap size

Aesthetic Medical International Holdings Group Limited(OTCPK:PAIY.Y) dropped from NASDAQ Composite Index

Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel

Aesthetic Medical International Holdings Group Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing

Full year 2023 earnings released: CN¥0.84 loss per share (vs CN¥2.79 loss in FY 2022)

Aesthetic Medical International Holdings Group Limited to Report Fiscal Year 2023 Final Results on Apr 25, 2024

New minor risk - Financial data availability

Aesthetic Medical International Holdings Announces Receipt of Letter of Expected Delisting Determination from Nasdaq Staff and Intention to Request Hearing Before the Nasdaq Hearings Panel

Aesthetic Medical International Holdings Group Limited Announces Change of Director

Aesthetic Medical International Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Second quarter 2023 earnings released: CN¥0.24 loss per share (vs CN¥0.062 loss in 2Q 2022)

Aesthetic Medical International Holdings Group Limited Announces Board and Committee Changes

An unknown buyer entered into an agreement to acquire Shenzhen Miaoyan Medical Technology Investment Co., Ltd. from Aesthetic Medical International Holdings Group Limited (NasdaqCM:AIH) for CNY 1.9 million.

Aesthetic Medical International Holdings Group Limited to Report Q1, 2023 Results on May 17, 2023

Full year 2022 earnings released: CN¥2.79 loss per share (vs CN¥26.68 loss in FY 2021)

Aesthetic Medical International Holdings Group Limited announced that it has received CNY 170.000002 million in funding from Hainan Oriental Jiechuang Investment Partnership (Limited Partnership)

Aesthetic Medical International Holdings Receives a Letter of Expected Delisting Determination from Nasdaq Staff and Requests a Hearing Before the Nasdaq Hearings Panel

Third quarter 2022 earnings released: CN¥1.12 loss per share (vs CN¥7.50 loss in 3Q 2021)

Aesthetic Medical International Holdings Group Limited to Report Q3, 2022 Results on Nov 29, 2022

Less than half of directors are independent

Second quarter 2022 earnings released: CN¥0.062 loss per share (vs CN¥1.65 loss in 2Q 2021)

Aesthetic Medical International Holdings Group Limited to Report First Half, 2022 Results on Aug 17, 2022

Aesthetic Medical International Holdings Group Limited, Annual General Meeting, Sep 08, 2022

Less than half of directors are independent

Aesthetic Medical International Holdings Group Limited announced that it expects to receive CNY 170.000002 million in funding from Hainan Oriental Jiechuang Investment Partnership

Aesthetic Medical International Holdings Group Limited announced that it has received CNY 99.999999 million in funding from Lafang China Co.,Ltd, Hawyu (HK) Limited

Aesthetic Medical International Receives Nasdaq Notice Regarding Non-Compliance with Minimum Stockholders’ Equity Requirement

Less than half of directors are independent

Aesthetic Medical International Announces Change of Board Members and Committee Composition

Less than half of directors are independent

Second quarter 2021 earnings released: CN¥1.65 loss per share (vs CN¥2.85 loss in 2Q 2020)

Less than half of directors are independent

First quarter 2021 earnings released: CN¥0.84 loss per share (vs CN¥3.66 loss in 1Q 2020)

Aesthetic Medical International Holdings Group Limited Provides Revenue Guidance for the Second Quarter of 2021

Aesthetic Medical International Holdings Group Limited announced that it expects to receive $15.099993 million in funding from Lafang China Co.,Ltd

Full year 2020 earnings released: EPS CN¥10.83 (vs CN¥8.87 in FY 2019)

Aesthetic Medical International Holdings Group Limited Reports Impairment of Non-Current Assets for the Fourth Quarter of 2020

CEO

Board Members

Average Tenure

Average Age